Safety and efficacy of rh-Lactoferrin in Diabetic Ulcers
Small Business Information
AGENNIX, INC., 8 GREENWAY PLZ, STE 910, HOUSTON, TX, 77046
AbstractDESCRIPTION (provided by applicant): Research Objectives: Determine the safety, pharmacokinetics, pharmacodynamics, and efficacy of topical recombinant human lactoferrin (rhLF) in promoting healing in diabetic ulcers. There are 7.5 million U
* information listed above is at the time of submission.